This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Typhus fever
AB1_TYPHUS_FEVER
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
12 |
4. Check minimum number of eventsNone |
12 |
5. Include endpointsNone |
12 |
6. Filter based on genotype QC (FinnGen only) |
12 |
Control definitions (FinnGen only)
- Control exclude
- AB1_RICKETTSIOSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Typhus fever
based on the number of shared cases.
Similar with more cases:
- Rickettsioses
- Certain infectious and parasitic diseases
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Paracetamol of NSAID medication
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 163 | 71 | 90 |
| Only index persons | 141 | 62 | 79 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 46.73 | 48.17 | 45.89 |
| Only index persons | 44.91 | 46.12 | 43.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 12 | 8 | - |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | - |
| Median age at first event (years) | 45.98 | 46.29 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
7
33
3.65
1.36
7.4
2.7
mmol/l
1.2
1.2
—
7
25
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
6
30
2.97
1.06
1.7
2.0
u/l
48.2
51.3
—
6
30
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
6
33
2.61
0.74
4.3
2.9
mmol/l
1.2
1.2
—
6
27
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5
31
2.04
0.51
2.6
3.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
14
0.00
0.44
0.0
3.0
—
0.7
—
0
6
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
17
0.00
0.44
0.0
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7
85
0.58
0.29
10.7
11.1
ml/min/173m2
93.0
86.0
—
7
69
(3003338) MCHC [Mass/volume]
7
81
0.68
0.27
19.9
13.9
g/l
324.7
331.4
—
7
81
(3022621) pH of Urine by Test strip
0
10
0.00
0.22
0.0
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7
62
1.31
0.12
5.4
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
6
62
0.94
0.00
3.3
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
17.5
—
0
5
(3025941) Bacteria identified in Stool by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
7
67
1.11
0.00
4.3
4.1
pmol/l
15.2
14.7
—
7
62
(3013707) Erythrocyte sedimentation rate by Westergren method
7
66
1.14
0.00
6.6
3.6
mm/h
9.7
9.6
—
7
61
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
0.9
—
0
5
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
0.2
—
0
7
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000492) Spirometry study
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
9
0.00
0.00
0.0
5.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7
70
1.00
0.00
6.1
6.6
u/l
80.3
72.1
—
7
63
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_TYPHUS_FEVER and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_TYPHUS_FEVER.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_TYPHUS_FEVER – Typhus fever
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data